News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Cancer Drug Suffers Patent Setback in India


8/6/2013 7:29:00 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

India has partly revoked patents granted to a Roche Holding AG breast cancer medicine, the Swiss firm said on Sunday, in the latest regulatory setback for western drugmakers trying to crack the fast-growing market. A Roche spokesman said the company was considering what further course of action to take. The Kolkata Patent Office said on Monday the company had failed to file its patent applications for Herceptin correctly and the patents had not been revoked.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
Roche
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES